New Jersey loses 800 pharma jobs

Schering-Plough will cut a minimum of 500 jobs starting on August 11th in New Jersey as part of a much larger plan to layoff 5,500 employees across the globe. At the same time, Johnson & Johnson will send about the same number of employees packing when it cuts nearly 300 jobs nationwide and shifts 260 positions out of New Jersey.

The Schering-Plough layoffs will be mainly be at its Kenilworth facility, but will also affect facilities in Berkeley Heights, Roseland, Springfield, Summit and Union. The shifted J&J positions will move to Pennsylvania and will become part of the company's Centocor subsidiary following a merger of the unit with its Ortho-Biotech unit. 

Abbott Labs also announced it would move 83 positions in Parsippany to its research headquarters in Abbott Park, IL, also in August.  

- read the full story at Newsday
- get the local news at NJ.com 
- here's more at the Pharmalot blog

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.